Related Experiment Video
Updated: Aug 3, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors
Angelo B A Laranjeira1, Melinda G Hollingshead1, Dat Nguyen1
1Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Abstract:
Role of DNA damage and demethylation on anticancer activity of DNA methyltransferase inhibitors (DNMTi) remains undefined. We report the effects of DNMT1 gene deletion/disruption (DNMT1-/-) on anticancer activity of a class of DNMTi in vitro, in vivo and in human cancers. The gene deletion markedly attenuated cytotoxicity and growth inhibition mediated by decitabine, azacitidine and 5-aza-4'-thio-2'-deoxycytidine (aza-T-dCyd) in colon and breast cancer cells. The drugs induced DNA damage that concurred with DNMT1 inhibition, subsequent G2/M cell-cycle arrest and apoptosis, and upregulated p21 in DNMT1+/+ versus DNMT1-/- status, with aza-T-dCyd the most potent. Tumor growth and DNMT1 were significantly inhibited, and p21 was upmodulated in mice bearing HCT116 DNMT1+/+ xenograft and bladder PDX tumors. DNMT1 gene deletion occurred in ~ 9% human colon cancers and other cancer types at varying degrees. Decitabine and azacitidine demethylated CDKN2A/CDKN2B genes in DNMT1+/+ and DNMT1-/- conditions and increased histone-H3 acetylation with re-expression of p16INK4A/p15INK4B in DNMT1-/- state. Thus, DNMT1 deletion confers resistance to DNMTi, and their anti-cancer activity is determined by DNA damage effects. Patients with DNMT1 gene deletions may not respond to DNMTi treatment.
Insights
DNA methyltransferase inhibitor (DNMTi) anticancer activity depends on DNA damage, not just demethylation. DNMT1 gene deletion reduces drug effectiveness, suggesting patients with these deletions may not benefit from DNMTi treatment.
Area of Science:
- Oncology
- Cancer Biology
- Epigenetics
Background:
- The precise role of DNA damage and demethylation in the anticancer efficacy of DNA methyltransferase inhibitors (DNMTi) is not fully understood.
- Investigating the impact of DNMT1 gene status on DNMTi response is crucial for optimizing cancer therapy.
Purpose of the Study:
- To elucidate the effect of DNMT1 gene deletion/disruption on the anticancer activity of DNMTi.
- To assess the influence of DNMT1 status on drug-induced DNA damage, cell cycle arrest, apoptosis, and gene expression in various cancer models.
Main Methods:
- In vitro studies using colon and breast cancer cell lines with and without DNMT1.
- In vivo studies involving mouse xenograft and patient-derived xenograft (PDX) tumor models.
- Analysis of human colon cancer samples for DNMT1 gene deletion frequency.
Main Results:
- DNMT1 gene deletion significantly attenuated the cytotoxicity and growth inhibition caused by decitabine, azacitidine, and aza-T-dCyd.
- DNMTi induced DNA damage, G2/M cell cycle arrest, apoptosis, and p21 upregulation in DNMT1+/+ cells, effects diminished in DNMT1-/- cells.
- DNMT1 deletion was observed in approximately 9% of human colon cancers, conferring resistance to DNMTi and impacting treatment response.
Conclusions:
- DNMT1 gene deletion confers resistance to DNMTi, indicating that their anticancer activity is primarily mediated by DNA damage effects.
- The re-expression of p16INK4A/p15INK4B via demethylation and histone acetylation occurs independently of DNMT1 status.
- Patients with DNMT1 gene deletions may exhibit a reduced response to DNMTi therapy, necessitating personalized treatment strategies.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Spontaneous and Induced Mutations
DNA Helicases

